Loading clinical trials...
Loading clinical trials...
A 28-Day Multiple-Dose Titration Study to Assess the Effects of MK-8892 on Safety, Tolerability and Pharmacokinetics in Subjects With Pulmonary Arterial Hypertension
Conditions
Interventions
MK-8892
Placebo for MK-8892
Start Date
November 14, 2013
Primary Completion Date
September 1, 2014
Completion Date
September 8, 2014
Last Updated
December 3, 2018
NCT06649110
NCT07218029
NCT06481852
NCT01347216
NCT05464095
NCT06954727
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions